OncoMatch/Clinical Trials/NCT07830576
Multimodal Survival Prediction Model for Colorectal Liver Metastases Post-Operation
Official title: Construction of a Post-operative Multimodal Survival Prediction Model for Patients With Colorectal Liver Metastases: A Study Based on the Fusion of a Multicenter Cohort and High-dimensional Radiomics
Is NCT07830576 recruiting? Yes, currently enrolling (Oct 2026).
The purpose of this study is to construct and validate a multimodal survival prediction model by integrating 3D radiomics features derived from preoperative magnetic resonance imaging (MRI) with systemic clinical baseline indicators for patients with colorectal liver metastases (CRLM) after surgery. By combining micro-level radiomics signatures reflecting tumor micro-heterogeneity with macro-level clinical parameters (such as liver function and tumor biomarkers), the study aims to accurately evaluate individual post-operative prognostic risks. This quantitative tool will provide reliable decision support for clinicians to customize post-operative follow-up and personalized adjuvant treatment strategies.
Check if I qualifyExtracted eligibility criteria
Cancer type
Colorectal Cancer
Disease stage
Metastatic disease required
Demographics
Prior therapy
Must have received: surgical resection for colorectal liver metastases
Underwent surgical resection for colorectal liver metastases
Cannot have received: local ablation only (such as radiofrequency ablation) without surgical resection
Patients who received local ablation only (such as radiofrequency ablation) without surgical resection
Structured fields extracted by AI. May contain errors — verify against the official protocol.
Frequently asked questions
Is NCT07830576 currently recruiting?
Yes, this trial is currently recruiting patients.
Are there prior therapy exclusions?
Yes. Prior local ablation only (such as radiofrequency ablation) without surgical resection disqualifies patients from enrollment.
Is there an age limit?
Yes. Patients must be 80 years or younger.
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualifyRelated pages